| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $122.4M | +16.0% |
| Cost of Revenue | $51.7M | -11.9% |
| Gross Profit | $70.6M | +50.9% |
| R&D Expense | $24.9M | -4.0% |
| SG&A Expense | $90.2M | -1.9% |
| Operating Income | -$49.7M | +51.1% |
| Pre-tax Income | -$31.6M | +67.3% |
| Income Tax | $719K | +1006.2% |
| Net Income | -$32.3M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $174.4M | -48.5% |
| Short-term Investments | $6.9M | — |
| Accounts Receivable | $25.4M | +33.6% |
| Inventory | $22.4M | +33.2% |
| Current Assets | $378.4M | -0.8% |
| Total Assets | $425.0M | -2.1% |
| Current Liabilities | $38.5M | +24.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.9M | +60.8% |
| Capital Expenditures | $3.8M | -67.7% |
| Investing Cash Flow | -$148.4M | -1224.3% |
| Financing Cash Flow | $2.7M | +16.4% |
| Free Cash Flow | -$22.7M | +62.2% |
| +66.6% |
| EPS (Basic) | -$0.86 | +67.0% |
| EPS (Diluted) | -$0.86 | +67.0% |
| Total Liabilities |
| $78.1M |
| +3.8% |
| Stockholders' Equity | $346.9M | -3.3% |